Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy
Atai Life Sciences, a Germany-based biopharmaceutical company, has become the latest publicly traded firm to adopt a Bitcoin treasury strategy. The Nasdaq-listed company, chaired by entrepreneur Christian Angermayer, announced plans to allocate a portion of its cash reserves into Bitcoin (BTC) as a hedge against inflation and a means of capital optimization amid challenging market […]
Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy Read More »